Sumitomo Mitsui Trust Group
SRTA

Sumitomo Mitsui Trust Group’s Strata Critical Medical Inc SRTA Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.55M Sell
1,052,611
-601,750
-36% -$3.17M ﹤0.01% 714
2026
Q1 		$6.92M Sell
1,654,361
-23,187
-1% -$112K ﹤0.01% 696
2025
Q4 		$8.07M Sell
1,677,548
-151,073
-8% -$731K ﹤0.01% 698
2025
Q3 		$9.25M Sell
1,828,621
-1,170,571
-39% -$5.17M 0.01% 687
2025
Q2 		$12.1M Hold
2,999,192
– – 0.01% 660
2025
Q1 		$8.19M Sell
2,999,192
-101,481
-3% -$364K 0.01% 705
2024
Q4 		$13.2M Sell
3,100,673
-659,089
-18% -$2.51M 0.01% 688
2024
Q3 		$11.1M Sell
3,759,762
-300,520
-7% -$957K 0.01% 703
2024
Q2 		$14.1M Buy
4,060,282
+381,308
+10% +$1.27M 0.01% 683
2024
Q1 		$10.5M Sell
3,678,974
-295,318
-7% -$911K 0.01% 763
2023
Q4 		$14M Sell
3,974,292
-285,969
-7% -$821K 0.01% 744
2023
Q3 		$11M Sell
4,260,261
-264,831
-6% -$930K 0.01% 770
2023
Q2 		$17.8M Sell
4,525,092
-257,547
-5% -$817K 0.01% 726
2023
Q1 		$16.2M Sell
4,782,639
-58,776
-1% -$240K 0.01% 741
2022
Q4 		$17.3M Sell
4,841,415
-32,366
-0.7% -$138K 0.01% 736
2022
Q3 		$19.6M Sell
4,873,781
-53,754
-1% -$276K 0.02% 701
2022
Q2 		$22M Buy
+4,927,535
New +$35.6M 0.02% 704
2022
Q1 		– Sell
-4,332,774
Closed -$38.3M – 1184
2021
Q4 		$38.3M Buy
4,332,774
+1,110,780
+34% +$10.6M 0.02% 616
2021
Q3 		$33.5M Buy
3,221,994
+1,575,574
+96% +$13.8M 0.02% 636
2021
Q2 		$17.3M Buy
1,646,420
+711,464
+76% +$7.02M 0.01% 742
2021
Q1 		$9.62M Buy
934,956
+919,355
+5,893% +$12.8M 0.01% 786
2020
Q4 		$173K Buy
+15,601
New +$159K ﹤0.01% 1110

Other funds holding SRTA

TP
Third Point New York $4.68B AUM 37.3% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $337M AUM 63.03% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
PLC
Pillsbury Lake Capital San Francisco, California $366M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sumitomo Mitsui Trust Group's SRTA Position: Q2 2026 in Review

Sumitomo Mitsui Trust Group reduced its Strata Critical Medical Inc (SRTA) stake by 36% in Q2 2026, selling an estimated $3.17M and leaving 1,052,611 shares worth $5.55M. The position accounts for ﹤0.01% of the portfolio, ranked #714.

Sumitomo Mitsui Trust Group first reported a position in SRTA in Q4 2020 and has held it in 22 quarters since. The position peaked at $38.3M in Q4 2021. 140 funds tracked by Wall St. Rank hold SRTA as of Q2 2026.

  • Sumitomo Mitsui Trust Group held 1,052,611 shares of Strata Critical Medical Inc worth $5.55M as of Q2 2026.
  • Sumitomo Mitsui Trust Group sold 601,750 Strata Critical Medical Inc shares in Q2 2026, an estimated $3.17M.
  • Strata Critical Medical Inc made up ﹤0.01% of Sumitomo Mitsui Trust Group's portfolio in Q2 2026, its #714 holding.
  • Sumitomo Mitsui Trust Group first reported a position in Strata Critical Medical Inc in Q4 2020 and has held it in 22 quarters since.
  • Sumitomo Mitsui Trust Group's Strata Critical Medical Inc position peaked at $38.3M in Q4 2021.
  • 140 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2026.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q2 2026, filed 30 Jul 2026.